ZENA.TO · Zenabis Global Inc

-

Please sign in to comment on ZENA.TO

1 Comment

Admin

4 years, 1 month ago

Zenabis Global Inc is currently in a long term uptrend where the price is trading 45.6% above its 200 day moving average.

From a valuation standpoint, the stock is 99.9% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.6.

Zenabis Global Inc's total revenue rose by 32.6% to $24M since the same quarter in the previous year.

Its net income has increased by 82.6% to $-17M since the same quarter in the previous year.

Finally, its free cash flow grew by 96.4% to $-4M since the same quarter in the previous year.

Based on the above factors, Zenabis Global Inc gets an overall score of 5/5.

ISIN	CA98936N1024
Industry	Drug Manufacturers - Specialty & Generic
Sector	Healthcare
Exchange	TO
CurrencyCode	CAD

Market Cap	148M
Beta	0.58
PE Ratio	None
Target Price	0.15
Dividend Yield	None

ABOUT

Zenabis Global Inc

Zenabis Global Inc. engages in the cultivation and sale of medical and adult-use recreational cannabis in Canada and internationally. The company produces and markets strains of dried cannabis under the Zenabis, Namaste, and Re-üp brands; and various oil-based cannabis products. It has 111,200 kg of licensed cannabis cultivation space in three licensed facilities in Canada. The company is headquartered in Vancouver, Canada. As of June 1, 2021, Zenabis Global Inc. operates as a subsidiary of HEXO Corp.

ZENA.TO · Zenabis Global Inc

-

Zenabis Global Inc

Earnings

Valuation

Cash Flow

Profitability

Performance

Backtest Zenabis Global Inc using a moving average strategy